These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 10400771)

  • 21. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium.
    Scaria A; St George JA; Jiang C; Kaplan JM; Wadsworth SC; Gregory RJ
    J Virol; 1998 Sep; 72(9):7302-9. PubMed ID: 9696826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
    Kaplan JM; St George JA; Pennington SE; Keyes LD; Johnson RP; Wadsworth SC; Smith AE
    Gene Ther; 1996 Feb; 3(2):117-27. PubMed ID: 8867859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated delivery of adeno-associated virus vectors to the rabbit airway.
    Beck SE; Jones LA; Chesnut K; Walsh SM; Reynolds TC; Carter BJ; Askin FB; Flotte TR; Guggino WB
    J Virol; 1999 Nov; 73(11):9446-55. PubMed ID: 10516053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.
    Setoguchi Y; Jaffe HA; Chu CS; Crystal RG
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):369-77. PubMed ID: 8136153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
    Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
    Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
    Hashimoto M; Boyer JL; Hackett NR; Wilson JM; Crystal RG
    Infect Immun; 2005 Oct; 73(10):6885-91. PubMed ID: 16177368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.
    Lee LY; Patel SR; Hackett NR; Mack CA; Polce DR; El-Sawy T; Hachamovitch R; Zanzonico P; Sanborn TA; Parikh M; Isom OW; Crystal RG; Rosengart TK
    Ann Thorac Surg; 2000 Jan; 69(1):14-23; discussion 23-4. PubMed ID: 10654479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia.
    Johnson LG; Pickles RJ; Boyles SE; Morris JC; Ye H; Zhou Z; Olsen JC; Boucher RC
    Hum Gene Ther; 1996 Jan; 7(1):51-9. PubMed ID: 8825868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated administration of adenovector in the eye results in efficient gene delivery.
    Hamilton MM; Brough DE; McVey D; Bruder JT; King CR; Wei LL
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):299-305. PubMed ID: 16384977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
    Croyle MA; Chirmule N; Zhang Y; Wilson JM
    J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a targeted gene vector platform based on simian adenovirus serotype 24.
    Belousova N; Mikheeva G; Xiong C; Soghomonian S; Young D; Le Roux L; Naff K; Bidaut L; Wei W; Li C; Gelovani J; Krasnykh V
    J Virol; 2010 Oct; 84(19):10087-101. PubMed ID: 20631120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
    Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
    Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-Antibody Complexes Contributed to Lethal Systemic Inflammation in a Gene Therapy Trial.
    Somanathan S; Calcedo R; Wilson JM
    Mol Ther; 2020 Mar; 28(3):784-793. PubMed ID: 32035027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.
    Rosengart TK; Lee LY; Patel SR; Kligfield PD; Okin PM; Hackett NR; Isom OW; Crystal RG
    Ann Surg; 1999 Oct; 230(4):466-70; discussion 470-2. PubMed ID: 10522716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.
    Hofmann C; Löser P; Cichon G; Arnold W; Both GW; Strauss M
    J Virol; 1999 Aug; 73(8):6930-6. PubMed ID: 10400791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.